HOME >> BIOLOGY >> NEWS
Significant pain reduction for post-shingles patients

Honolulu, HI April 1, 2003 -- NeurogesX, Inc. today announced Phase II results of a treatment for post-shingles pain, a severe pain condition that affects an estimated 400,000 Americans. The study results demonstrated that a single dose of a capsaicin-containing dermal patch provided a 33% reduction in pain scores over the course of four weeks, compared to 4% with control treatment. The results of the clinical trial were disclosed at a late-breaking science presentation made today at the American Academy of Neurologys annual meeting by Dr. Misha-Miroslav Backonja, an investigator in the study and Director of Research and Education of the University of Wisconsin Pain Treatment Center in Madison, Wisconsin.

The study demonstrates that long-term pain relief may be provided by a single application of high-concentration capsaicin patches, said Dr. Backonja. Importantly, because the patch-based treatment is localized, the systemic side effects of traditional treatments may be avoided. Despite expected pain increases during the procedure due to the pungent nature of capsaicin, overall tolerability was good. Dr. Backonja said no safety concerns were identified. A plasma sample analysis of patients confirmed the lack of systemic capsaicin absorption.

Postherpetic Neuralgia
Every year, nearly 1 million Americans get shingles, a condition caused by varicella-zoster virus, the virus that also causes chickenpox. The condition usually results in a rash, blistering and, in many cases, severe pain. Many patients continue to have severe pain even after the rash disappears. This condition is called postherpetic neuralgia. It often persists for many years. Most current pain treatments for this pain syndrome require multiple doses each day and can cause side effects such as fatigue, light-headedness, fluid retention, constipation or dry mouth.

Capsaicins Pain Relief Impact
Capsaicin, the pungent ingredient in hot chili peppers, activa
'"/>

Contact: Mike Jackman
mike@jackman.com
415-388-3216
Jackman Communications
1-Apr-2003


Page: 1 2 3

Related biology news :

1. Significant strides in small regulatory RNA research in plants
2. Significant health benefits of a daily fish meal as part of a weight loss regimen
3. Genetics Not Significant To Developing Typical Parkinsons Disease
4. Some Smelter Slags Represent A Significant Environmental Hazard
5. Chiron Discovers Significant Hepatitis C Binding Mechanism; Data Indicates CD81 Protein May Be A Virus Receptor
6. Antioxidant Action Of Vitamin E Significantly Reduces Heart Disease In Mice
7. Study Shows First Significant Genetic Evidence For Schizophrenia Susceptibility
8. Subtle Changes In Brain Receptor Gene May Have Significant Consequences For Addiction
9. Children With AD/HD Have Significant Functional Disabilities Related to Attention Deficit
10. Will a reduction in military spending improve our environmental future?
11. Sequencing project results in six-fold reduction of effective size of maize genome

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:4/19/2017)... 2017 The global military biometrics ... marked by the presence of several large global players. ... five major players - 3M Cogent, NEC Corporation, M2SYS ... nearly 61% of the global military biometric market in ... global military biometrics market boast global presence, which has ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... business process optimization firm for the life sciences and healthcare industries, announces a ... in San Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... ... a four-tiered line of medical marijuana products targeting the needs of consumers who ... packaging of Kindred takes place in Phoenix, Arizona. , As operators of two ...
(Date:10/6/2017)... ... October 06, 2017 , ... The ... and technology sector at their fourth annual Conference where founders, investors, innovative practitioners ... and the ELEVATE pitch competition showcasing early stage digital health and med tech ...
Breaking Biology Technology:
Cached News: